PIK3CG overexpression
|
SCCHN
|
PIK3CG overexpression
|
SCCHN
|
duvelisib Sensitive: D – Preclinical
|
duvelisib Sensitive: D – Preclinical
|
PIK3CG overexpression
|
Melanoma
|
PIK3CG overexpression
|
Melanoma
|
duvelisib Sensitive: D – Preclinical
|
duvelisib Sensitive: D – Preclinical
|